Align Technology | ALGN - 税前利润



金融业
股票价格
USD
资产
USD 6.31B
现金及等价物
USD 1.06B
销售成本
USD 303.5M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 114.45M
EBIT
USD 178.05M
EBITDA
USD 260.87M
员工
20.95K
EPS每股收益
USD 2.58
股本和储备
USD 4.15B
销售毛利
USD 736.59M
债务利息支出
USD 16.05M
利息收入
USD 4.62M
贷款资金
USD 0
市值
USD 13.4B
净收入
USD 112.77M
营业费用
USD 862.03M
营业利润
USD 178.05M
普通股股本
USD 71.62M
PE价格收益
22.78
税前利润
USD 148.89M
销售收入
USD 1.04B
销售和管理费用
USD 465.34M
股票
USD 214.94M
贸易债权人
USD 123.72M
应收帐款人
USD 1.13B


税前利润 更改 日
3M USD 878M 119M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cardinal Health USD 630M 32M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cooper Companies USD 192.2M 75.4M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Henry Schein USD 150M 17M 2026-03
Idexx Laboratories USD 355.44M 48.46M 2026-03
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
McKesson USD 1.63B 235M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Solventum Corp USD 332M 179M 2025-12
Stryker USD 1.7B 676M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veeva Systems USD 469.79M 152.26M 2026-03
Waters USD 264.18M 94.06M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 761M 126M 2025-12